Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy

Lancet

Volumn 363, Issue 9411, 2004, Pages 746-747

  Matsubara, Hiroaki ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEART ENZYME;

ACUTE HEART INFARCTION; ANGIOGENESIS; BLOOD VESSEL OCCLUSION; BONE MARROW; BONE MARROW TRANSPLANTATION; CORONARY ARTERY; CORONARY RISK; DRUG SAFETY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC TISSUE; HUMAN; INTRACORONARY INFUSION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; UNSTABLE ANGINA PECTORIS;

EID: 1542345697     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15713-9     Document Type: Note

References (14)

1. Korbling M., Estrov Z. Adult stem cells for tissue repair - new therapeutic concept? N Engl J Med. 349:2003;570-582.
2. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet. 360:2002;427-435.
3. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:2002;1913-1918.
4. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 106:2002;3009-3017.
5. Stamm C., Westphal B., Kleine H-D, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 361:2003;45-46.
6. Tse H-F, Kwong Y-L, Chan J.K.F., et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 361:2003;47-49.
7. Perin E.C., Dohmann H.F.R., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2003;2294-2302.
8. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:2001;10344-10349.
9. Norol F., Merlet P., Sebillon P., et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood. 102:2003;4361-4368.
10. Hill JM, Paul JD, Powell TM, et al. Efficacy and risk of granulocyte colony stimulating factor administration in patients with severe coronary artery disease. Circulation 2003; 108 (supp IV): 478.
11. Fukumoto Y., Miyamoto T., Okamura T., et al. Angina pectoris occuring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haem. 97:1997;666-668.
12. Kamihata H., Matsubara H., Nishiue N., et al. Improvement of collateral perfusion and regional function by catheter-based implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol. 22:2002;1804-1810.
13. Inaba S, Egashira K, Kimihiro, et al. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet 2002; 360: 2083-84.
14. Iba O., Matsubara H., Nozawa Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs Circulation. 106:2002;2019-2025.